Please log in to access this page.

Ocular pemphigoid: treatments, associated drugs and conditions

Summary:

Ocular pemphigoid: inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye.

We study 312 people who have Ocular pemphigoid. The information that eHealthMe analyzes includes:

- Medications that treat Ocular pemphigoid and their effectiveness
- 15 drugs that are associated with Ocular pemphigoid


eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


Number of reports submitted per year:

Ocular pemphigoid: 312 reports.

All the drugs that are associated with Ocular pemphigoid:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.



Recent studies on eHealthMe: